-
Signature
-
/s/ Brian Grube, Attorney-in-Fact
-
Issuer symbol
-
INTA
-
Transactions as of
-
09 Dec 2024
-
Net transactions value
-
-$1,279,557
-
Form type
-
4
-
Filing time
-
11 Dec 2024, 16:12:16 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
INTA |
Common Stock |
Options Exercise |
$79,800 |
+20,000 |
+2.5% |
$3.99 |
818,222 |
09 Dec 2024 |
Direct |
F1 |
| transaction |
INTA |
Common Stock |
Sale |
$96,602 |
-1,443 |
-0.18% |
$66.94 |
816,779 |
09 Dec 2024 |
Direct |
F1, F2 |
| transaction |
INTA |
Common Stock |
Sale |
$366,440 |
-5,435 |
-0.67% |
$67.42 |
811,344 |
09 Dec 2024 |
Direct |
F1, F2 |
| transaction |
INTA |
Common Stock |
Sale |
$896,315 |
-13,122 |
-1.6% |
$68.31 |
798,222 |
09 Dec 2024 |
Direct |
F1, F2 |
| holding |
INTA |
Common Stock |
|
|
|
|
|
34,972 |
09 Dec 2024 |
By Spouse |
F3 |
| holding |
INTA |
Common Stock |
|
|
|
|
|
15,028 |
09 Dec 2024 |
By Trust |
F4 |
| holding |
INTA |
Common Stock |
|
|
|
|
|
15,028 |
09 Dec 2024 |
By Trust |
F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
INTA |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-20,000 |
-22% |
$0.000000 |
69,198 |
09 Dec 2024 |
Common Stock |
20,000 |
$3.99 |
Direct |
F1, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: